Treatment of Retinal Vasculitis with Macular Edema and Significant Loss of Visual Acuity

In its most severe form, retinal vasculitis presents with substantial reduction in visual acuity, macular edema, and extensive retinal involvement — a constellation that demands a structured, targeted management approach.

Clinical Scenario

Patients in this category present with significant loss of visual acuity, macular edema, and extensive retinal involvement — the most severe end of the retinal vasculitis spectrum, where both the macula and broad retinal areas are affected and vision is materially compromised.

Treatment Approach (partial overview)

Management of the macular edema involves intravitreal intervention — specific agent selection depends on the clinical picture. Where complications such as neovascularization or vitreous hemorrhage arise, procedural options form part of the approach.

The full structured regimen — including agent selection, sequencing, and procedural indications — is available in the complete protocol below.

Instant Access to Structured Evidence-Based Regimens

References

In the most severe cases, with significant loss of visual acuity, macular edema, and extensive retinal involvement, the use of systemic corticosteroid therapy (oral or intravenous) is indicated.

The use of anti-vascular endothelial growth factor antibodies as well as corticosteroids in the form of intravitreal injections can be attempted to manage complications such as macular edema.

Vitrectomy and laser photocoagulation are indicated in cases of persistent neovascularization, vitreous hemorrhage or glaucoma.

DOI: 10.25259/JORP_34_2024

View source ↗